To test whether this is also the case in humans, we analyzed the infiltration of CD4+ and CD8+ effector T cells and Tregs in liver biopsies from 32 patients diagnosed with MASLD. This evidence concerns the gene CD8A and metabolic dysfunction-associated steatotic liver disease.